Rapid genotyping for antiplatelet therapy. 1 in 3 people carry mutations. 30 percent of Caucasians and 40 percent of Asians carry CYP2C19 mutations that impair drug metabolism. For heart attack patients, most complications from poor Plavix® response occur in the first 24 to 48 hours after cardiac stenting. ...
By Genomadix based in Ottawa, ONTARIO (CANADA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you